Calcium-Dependent and Oncogenic IL-3 mRNA Stabilization can be Distinguished Pharmacologically and by Sequence Requirements in the 3′UTR

References

• Blochlinger K., Diggelmann H. Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells. Mol. Cell Biol 1984; 4: 2929–31
   PubMed Web of Science ®Google Scholar
• Campbell H. D., Ymer S., Fung M. C., Young I. G. Cloning and nucleotide sequence of the murine interleukin-3 gene. Eur. J. Biochem 1985; 150: 297–304
   PubMedGoogle Scholar
• Chen C. Y., Del Gatto-Konczak F., Wu Z., Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 1998; 280: 1945–9
   PubMed Web of Science ®Google Scholar
• Chen C. Y., Shyu A. B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci 1995; 20: 465–70
   PubMed Web of Science ®Google Scholar
• Clipstone N. A., Crabtree G. R. Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506. Ann. NY Acad. Sci 1993; 696: 20–30
   PubMed Web of Science ®Google Scholar
• Cuturi M. C., Anegon I., Sherman F., Loudon R., Clark S. C., Perussia B., Trinchieri G. Production of hematopoietic colony-stimulating factors by human natural killer cells. J. Exp. Med 1989; 169: 569–83
   PubMed Web of Science ®Google Scholar
• Diamantis I. D., Nair A. P., Hirsch H. H., Moroni C. Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells. Proc. Natl. Acad. Sci. USA 1989; 86: 9299–303
   PubMed Web of Science ®Google Scholar
• Duncliffe K. N., Bert A. G., Vadas M. A., Cockerill P. N. A T cell-specific enhancer in the interleukin-3 locus is activated cooperatively by Oct and NFAT elements within a DNase I-hypersensitive site. Immunity 1997; 6: 175–85
   PubMed Web of Science ®Google Scholar
• Gough N. M. Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal. Biochem 1988; 173: 93–5
   PubMed Web of Science ®Google Scholar
• Herrick D. J., Ross J. The half-life of c-myc mRNA in growing and serum-stimulated cells: influence of the coding and 3′-untranslated regions and role of ribosome trans-location. Mol. Cell Bid 1994; 14: 2119–28
   Google Scholar
• Hirsch H. H., Backenstoss V., Moroni C. Impaired interleukin-3 mRNA decay in autocrine mast cell tumors after transient calcium ionophore stimulation. Grow. Fact 1996; 13: 99–110
   PubMed Web of Science ®Google Scholar
• Hirsch H. H., Nair A. P., Backenstoss V., Moroni C. Interleukin-3 mRNA stabilization by a trans-acting mechanism in autocrine tumors lacking interleukin-3 gene rearrangements. J. Bid. Chem 1995; 270(20)629–35
   Google Scholar
• Hirsch H. H., Nair A. P., Moroni C. Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukin 3 gene. J. Exp. Med 1993; 178: 403–11
   PubMed Web of Science ®Google Scholar
• Ihle J. N. Interleukin-3 and hematopoiesis. Chem. Immunol 1992; 51: 65–106
   PubMed Web of Science ®Google Scholar
• Ihle J. N., Morishita K., Bartholomew C., Matsugi T., Askew D. Phenotypes and mechanisms in the transformation of hematopoietic cells. Int. J. Cell Cloning 1990; 8(Suppl. 1)130–46
   PubMedGoogle Scholar
• Iwai Y., Bickel M., Pluznik D. H., Cohen R. B. Identification of sequences within the murine granulocyte-macrophage colony-stimulating factor mRNA 3′-untrans-lated region that mediate mRNA stabilization induced by mitogen treatment of EL-4 thymoma cells. J. Biol. Chem 1991; 266: 17959–65
   PubMed Web of Science ®Google Scholar
• Karasuyama H., Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol 1988; 18: 97–104
   PubMed Web of Science ®Google Scholar
• Kelso A., Gough N. M. Differential inhibition by cyclosporin A reveals two pathways for activation of lympho-kine synthesis in T cells. Grow. Fact 1989; 1: 165–77
   PubMed Web of Science ®Google Scholar
• Lagnado C. A., Brown C. Y., Goodall G. J. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell Biol 1994; 14: 7984–95, issn: 0270–7306
   PubMed Web of Science ®Google Scholar
• Lee J. C., Laydon J. T., McDonnell P. C., Gallagher T. F., Kumar S., Green D., MeNulty D., Blumenthal M. J., Heys J. R., Landvatter S. W., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372: 739–46
   PubMed Web of Science ®Google Scholar
• Liu J., Farmer J. D., Jr., Lane W. S., Friedman J., Weissman I., Schreiber S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP. Cell 1991; 66: 807–15
   PubMed Web of Science ®Google Scholar
• Meeker T. C., Hardy D., Willman C., Hogan T., Abrams J. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia (see comments). BIood 1990; 76: 285–9
   Google Scholar
• Ming X. F., Kaiser M., Moroni C. c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. EM BO J 1998; 17: 6039–48
   PubMed Web of Science ®Google Scholar
• Nair A. P., Diamantis I. D., Conscience J. F., Kindler V., Hofer P., Moroni C. A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production. Mol. Cell Biol 1989; 9: 1183–90
   PubMed Web of Science ®Google Scholar
• Nair A. P., Hahn S., Banholzer R., Hirsch H. H., Moroni C. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA. Nature 1994; 369: 239–42
   PubMed Web of Science ®Google Scholar
• Nair A. P., Hirsch H. H., Moroni C. Mast cells sensitive to v-H-ras transformation are hyperinducible for interleukin 3 expression and have lost tumor-suppressor activity. Oncogene 1992; 7: 1963–72
   PubMed Web of Science ®Google Scholar
• Niemeyer C. M., Sieff C. A., Mathey-Prevot B., Wimperis J. Z., Bierer B. E., Clark S. C., Nathan D. G. Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines. Blood 1989; 73: 945–51
   PubMed Web of Science ®Google Scholar
• Peng S. S., Chen C. Y., Shyu A. B. Functional characterization of a non-AUUUA AU-rich element from the c-jun proto-oncogene mRNA: evidence for a novel class of AU-rich elements. Mol. Cell Biol 1996; 16: 1490–9
   PubMed Web of Science ®Google Scholar
• Plaut M., Pierce J. H., Watson C. J., Hanley-Hyde J., Nordan R. P., Paul W. E. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 1989; 339: 64–7
   PubMed Web of Science ®Google Scholar
• Ryan G. R., Milton S. E., Lopez A. F., Bardy P. G., Vadas M. A., Shannon M. F. Human interleukin-3 mRNA accumulation is controlled at both the transcriptional and posttranscriptional level. BIood 1991; 77: 1195–202
   Google Scholar
• Schiavi S. C., Wellington C. L., Shyu A. B., Chen C. Y., Greenberg M. E., Belasco J. G. Multiple elements in the c-fos protein-coding region facilitate mRNA deadenylation and decay by a mechanism coupled to translation. J. Biol. Chem 1994; 269: 3441–8
   PubMed Web of Science ®Google Scholar
• Shaw G., Kamen R. A conserved AU sequence from the 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46: 659–67
   PubMed Web of Science ®Google Scholar
• Shyu A. B., Belasco J. G., Greenberg M. E. Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev 1991; 5: 221–31
   PubMed Web of Science ®Google Scholar
• Stoecklin C., Hahn S., Moroni C. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. J. Bid. Chem 1994; 269: 28591–7
   PubMed Web of Science ®Google Scholar
• Wodnar-Filipowicz A., Heusser C. H., Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989; 339: 150–2
   PubMed Web of Science ®Google Scholar
• Wodnar-Filipowicz A., Moroni C. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. Proc. Natl. Acad. Sci. USA 1990; 87: 777–81
   PubMed Web of Science ®Google Scholar
• Xu N., Chen C. Y., Shyu A. B. Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol. Cell. Bid 1997; 17: 4611–21
   Google Scholar
• Zubiaga A. M., Belasco J. G., Greenberg M. E. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell Biol 1995; 15: 2219–30, ism: 0270–7306
   PubMed Web of Science ®Google Scholar